CONMED Corp — Director's Dealing 2012

Mar 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-03-01

Reporting Person: Cohen Heather L (VP CORP HR&DEPUTY GEN COUNSEL)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-01	Common Stock	M	2000	$16.46	Acquired	5926	Direct
2012-03-01	Common Stock	F	1425	$29.99	Disposed	4501	Direct
2012-03-01	Common Stock	M	2000	$19.26	Acquired	6501	Direct
2012-03-01	Common Stock	F	1545	$29.99	Disposed	4956	Direct
2012-03-01	Common Stock	M	500	$19.93	Acquired	5456	Direct
2012-03-01	Common Stock	F	394	$29.99	Disposed	5062	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-01	Sars (Stock Appreciation Rights)	$16.46	M	2000	Disposed	2019-06-01	Common Stock (2000)	Direct
2012-03-01	Sars (Stock Appreciation Rights)	$19.26	M	2000	Disposed	2020-06-01	Common Stock (2000)	Direct
2012-03-01	Sars (Stock Appreciation Rights)	$19.93	M	500	Disposed	2016-05-16	Common Stock (500)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F2: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.